A61N1/0546

Systems and methods for therapeutic nasal neuromodulation
11576719 · 2023-02-14 · ·

The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.

Systems and methods for therapeutic nasal neuromodulation
11547472 · 2023-01-10 · ·

The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.

SYSTEMS AND METHODS FOR STIMULATION
20230023475 · 2023-01-26 · ·

A stimulation device may include a tube, where the tube defines a lumen therein and a gas outlet. The gas outlet may be configured to allow gas to pass from the lumen to an exterior of the tube. The stimulation device may also include one or more first electrodes associated with the tube, one or more second electrodes, and a nasal cavity interface proximal of the gas outlet and the one or more first electrodes.

Systems and methods for therapeutic nasal neuromodulation
11701167 · 2023-07-18 · ·

The invention generally relates to systems and methods for therapeutically modulating nerves in or associated with a nasal region of a patient for the treatment of a rhinosinusitis condition.

Devices for therapeutic nasal neuromodulation and associated methods and systems

A device for therapeutic neuromodulation in a nasal region can include, for example, a shaft and a therapeutic element at a distal portion of the shaft. The shaft can locate the distal portion intraluminally at a target site inferior to a patient's sphenopalatine foramen. The therapeutic element can include an energy delivery element configured to therapeutically modulate postganglionic parasympathetic nerves at microforamina of a palatine bone of the human patient for the treatment of rhinitis or other indications. In other embodiments, the therapeutic element can be configured to therapeutically modulate nerves that innervate the frontal, ethmoidal, sphenoidal, and maxillary sinuses for the treatment of chronic sinusitis.

NASAL NERVE DENERVATION INSTRUMENT WITH DENERVATION CONFIRMATION

An apparatus includes a shaft assembly, first and second electrode assemblies, and a controller. The shaft assembly is configured to fit in a nasal cavity of a patient. The first and second electrode assemblies are at the distal end of the shaft assembly. The second electrode assembly includes a stimulus electrode and a sensing electrode. The stimulus and sensing electrodes are positioned on opposing lateral sides in relation to the longitudinal axis of the shaft assembly. The controller is operable to generate an electrical signal to perform one or both of tissue ablation or denervation of a targeted nerve via the first electrode assembly, generate an electrical stimulus signal to stimulate the targeted nerve via the stimulus electrode of the second electrode assembly, and process a response signal received from the targeted nerve via the sensing electrode of the second electrode assembly.

DEVICE FOR PREVENTING SLEEP APNEA AND SNORING
20220401253 · 2022-12-22 ·

A device for preventing sleep apnea and snoring, which is shaped like a semi-rigid whip. This whip has a curve that goes according to the anatomy of the base of the nasal cavity. At the wavy end of the whip is a design in the shape of the letter M that keeps the device fixed to the nostrils and, in turn, helps expand wing and triangular cartilages.

Device and method to selectively and reversibly modulate a nervous system structure to inhibit the perception of pain

The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neural- and non-neural tissue of the nervous structure, inhibiting the perception of pain while preserving other sensory and motor function, and proprioception.

SYSTEMS AND METHODS FOR TARGETED THERAPEUTIC NASAL NEUROMODULATION
20220361941 · 2022-11-17 ·

The invention provides systems and methods providing precision targeting of neural structures for the treatment of a condition while avoiding collateral damage to surrounding structures, such as blood vessels and/or other nerve tissue. The invention further provides systems and methods for treating at least one of rhinitis, congestion, and/or rhinorrhea via thrombus formation. The invention further provides systems and methods for detection, identification, and precision targeting of neural tissue for the treatment of a neurological condition while minimizing or avoiding collateral damage to surrounding or adjacent non-neural tissue, such as blood vessels and bone, as well as non-targeted neural tissue.

DEVICE AND METHOD TO SELECTIVELY AND REVERSIBLY MODULATE A NERVOUS SYSTEM STRUCTURE TO INHIBIT THE PERCEPTION OF PAIN

The present disclosure is directed to a system and method for selectively and reversibly modulating targeted neural and non-neural tissue of a nervous system for the treatment of pain. An electrical stimulation is delivered to the treatment site that selectively and reversibly modulates the targeted neutral- and non-neural tissue of the nervous structure, inhibiting the perception of pain while preserving other sensory and motor function, and proprioception.